首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ad26.cov2-s/tozinameranAcute limb ischaemia secondary to thrombotic thrombocytopenia: 3 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2023年
/ 1985卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-023-50792-8
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:22 / 22
相关论文
共 50 条
[31]
AZD-1222/Ad26.COV2-S/tozinameranVaccine-induced immune thrombotic thrombocytopenia
Reactions Weekly,
2024,
2001
(1)
: 64
-
64
[32]
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
Yocum, Andrew
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Akron Gen, Dept Emergency Med, 1 Akron Gen Ave, Akron, OH 44307 USA
Northeast Ohio Med Univ, Rootstown, OH USA
Cleveland Clin Akron Gen, Dept Emergency Med, 1 Akron Gen Ave, Akron, OH 44307 USA
Yocum, Andrew
Simon, Erin L.
论文数:
0
引用数:
0
h-index:
0
机构:
Cleveland Clin Akron Gen, Dept Emergency Med, 1 Akron Gen Ave, Akron, OH 44307 USA
Northeast Ohio Med Univ, Rootstown, OH USA
Cleveland Clin Akron Gen, Dept Emergency Med, 1 Akron Gen Ave, Akron, OH 44307 USA
Simon, Erin L.
AMERICAN JOURNAL OF EMERGENCY MEDICINE,
2021,
49
: 441.e3
-
441.e4
[33]
Ad26.COV2-S/elasomeran/tozinameranAcute kidney injury, injection-site pain and nephrotic syndrome: 6 case reports
Reactions Weekly,
2023,
1963
(1)
: 19
-
19
[34]
Ad26.COV2-S/elasomeranAcute myocardial infarction and myocarditis: 2 case reports
Reactions Weekly,
2023,
1986
(1)
: 19
-
19
[35]
Ad26.cov2-s/argatroban/immune-globulinVaccine-induced immune thrombotic thrombocytopenia and lack of efficacy: case report
Reactions Weekly,
2023,
1945
(1)
: 19
-
19
[36]
Ad26.COV2-S/tozinameranMyopericarditis and unmasking of autoimmune condition: 6 case reports
Reactions Weekly,
2022,
1933
(1)
: 18
-
18
[37]
Ad26.cov2-s/immune-globulinImmune mediated thrombocytopenia and no response: case report
Reactions Weekly,
2021,
1873
(1)
: 18
-
18
[38]
Ad26.COV2-S/heparinVaccine induced thrombocytopenia and thrombosis and frontoparietal haemorrhage: case report
Reactions Weekly,
2022,
1929
(1)
: 17
-
17
[39]
Ad26.cov2-s/azd-1222/tozinameranMyocarditis: 15 case reports
Reactions Weekly,
2023,
1948
(1)
: 19
-
19
[40]
Ad26.cov2-s/elasomeran/tozinameranVaccine breakthrough infection: 76 case reports
Reactions Weekly,
2022,
1897
(1)
: 21
-
21
←
1
2
3
4
5
→